mianserin has been researched along with Bradycardia in 4 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An acute episode of symptomatic sinus bradycardia, occurred in a 50-year-old female patient after she had been given a single therapeutic dose of mianserin." | 7.68 | Symptomatic bradycardia caused by mianserin at therapeutic doses. ( Carcone, B; Chaillet, N; Descotes, J; Vial, T, 1991) |
| "An acute episode of symptomatic sinus bradycardia, occurred in a 50-year-old female patient after she had been given a single therapeutic dose of mianserin." | 3.68 | Symptomatic bradycardia caused by mianserin at therapeutic doses. ( Carcone, B; Chaillet, N; Descotes, J; Vial, T, 1991) |
| "Mirtazapine is a commonly prescribed antidepressant drug, which is also metabolized through and may modulate the CYP4502D6 pathway leading to altered metabolism of propafenone and possible adverse effects." | 1.40 | Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction. ( Aryal, SR; Khan, MA; Rajpurohit, N; Stys, AT; Stys, TP, 2014) |
| "Serotonin syndrome is caused by excess serotonin in the central nervous system." | 1.37 | [Serotonin syndrome in the course of drug-poisoning--case presentation]. ( Kostek, H; Kujawa, A; Majewska, M; Pyra, E; Szponar, J, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajpurohit, N | 1 |
| Aryal, SR | 1 |
| Khan, MA | 1 |
| Stys, AT | 1 |
| Stys, TP | 1 |
| Koseoglu, Z | 1 |
| Kara, B | 1 |
| Satar, S | 1 |
| Majewska, M | 1 |
| Szponar, J | 1 |
| Pyra, E | 1 |
| Kostek, H | 1 |
| Kujawa, A | 1 |
| Carcone, B | 1 |
| Vial, T | 1 |
| Chaillet, N | 1 |
| Descotes, J | 1 |
4 other studies available for mianserin and Bradycardia
| Article | Year |
|---|---|
Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction.
Topics: Aged; Anti-Arrhythmia Agents; Antidepressive Agents, Tricyclic; Atrial Fibrillation; Bradycardia; Di | 2014 |
Bradycardia and hypotension in mianserin intoxication.
Topics: Adult; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Atropine; Bradycardia; Fema | 2010 |
[Serotonin syndrome in the course of drug-poisoning--case presentation].
Topics: Alcoholic Intoxication; Alkaloids; Azocines; Bradycardia; Cyclohexanols; Depressive Disorder; Electr | 2011 |
Symptomatic bradycardia caused by mianserin at therapeutic doses.
Topics: Bradycardia; Electrocardiography; Female; Humans; Mianserin; Middle Aged | 1991 |